ArticlePhysica A2022
An extended epidemic model with vaccination: Weak-immune SIRVI.
Article in Physica A, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 43 citations in OpenAlex.
- Solving age-dependent infectious diseases and tumor growth models using the contraction approach.MethodsX · 2025Article
- An effective drift-diffusion model for pandemic propagation and uncertainty prediction.Biophysical reports · 2024Article
- Influence of waning immunity on vaccination decision-making: A multi-strain epidemic model with an evolutionary approach analyzing cost and efficacy.Infectious Disease Modelling · 2024Article
- Endemic characteristics of SARS-CoV-2 infection.Scientific reports · 2023Article
- Analysis of SIRVI model with time dependent coefficients and the effect of vaccination on the transmission rate and COVID-19 epidemic waves.Infectious Disease Modelling · 2023Article
- Risk factors associated with indoor transmission during home quarantine of COVID-19 patients.Frontiers in public health · 2023Article
- Machine learning models for prediction of HF and CKD development in early-stage type 2 diabetes patients.Scientific reports · 2022Article
- Stability and bifurcation control analysis of a delayed fractional-order eco-epidemiological system.European physical journal plus · 2022Article
- Caputo Fractal Fractional Order Derivative of Soil Pollution Model Due to Industrial and Agrochemical.International journal of applied and computational mathematics · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A new modification of the SIR epidemic model incorporating vaccination is proposed in the present paper. The recent trend of vaccinating against COVID-19 pandemic reveals a strong control of infectious disease. On the other hand, it is observed in some countries that, the vaccine application offers less control over the spread of virus, since some portion of vaccinated people is not totally protected/immuned and viable to infection again after a while due to weak/loss immunity offered by the vaccine. This requires transition from vaccinated department to infected for COVID-19. This character of COVID-19 helps us reconsideration of the vaccinated department by letting some part of it being exposed to the infection again. Taking this into account, as a result of modification of the SIR model, the epidemiology is now governed with three main epidemic dimensionless parameters, having provided an initial fraction of infected individuals. The dimensionless model with these parameters is analyzed initially from the stability point of view. The effects of weak immunity are then illustrated numerically on some chosen parameter range. How some of the countries applying the COVID-19 vaccine programs affected by weak/loss immunity is eventually examined with the modified model. The rate of vaccination as well as the basic Reproduction number are found to affect the epidemic demography of the population subject to weak or loss of immunity. In the case of a high vaccination rate, the countries are not anticipated to be highly influenced by the weak immunity of low level, whereas weak immunity prolongs the contagious disease by appearance of secondary multiple peaks in the epidemic compartments with relatively small vaccination rates and basic Reproductive numbers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.